The activation of OR51E1 causes growth suppression of human prostate cancer cells

by Maßberg, D, Jovancevic, N, Offermann, A, Simon, A, Baniahmad, A, Perner, S, Pungsrinont, T, Luko, K, Philippou, S, Ubrig, B, Heiland, M, Weber, L, Altmüller, J, Becker, C, Gisselmann, G, Gelis, L, Hatt, H
Published 2020

Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity

by Koch, C., Kuske, A., Joosse, S.A., Yigit, G., Sflomos, G., Thaler, S., Smit, D.J., Werner, S., Borgmann, K., Gärtner, S., Mossahebi Mohammadi, P., Battista, L., Cayrefourcq, L., Altmüller, J., Salinas-Riester, G., Raithatha, K., Zibat, A., Goy, Y., Ott, L., Bartkowiak, K., Tan, T.Z., Zhou, Q., Speicher, M.R., Müller, V., Gorges, T.M., Jücker, M., Thiery, J.-P., Brisken, C., Riethdorf, S., Alix-Panabières, C., Pantel, K.
Published 2021

Evaluation of presumably disease causing SCN1A variants in a cohort of common epilepsy syndromes

by Lal D., Reinthaler E.M., Dejanovic B., May P., Thiele H., Lehesjoki A.-E., Schwarz G., Riesch E., Ikram M.A., Van Duijn C.M., Uitterlinden A.G., Hofman A., Steinböck H., Gruber-Sedlmayr U., Neophytou B., Zara F., Hahn A., Gormley P., Becker F., Weber Y.G., Cilio M.R., Kunz W.S., Krause R., Zimprich F., Lemke J.R., Nürnberg P., Sander T., Lerche H., Neubauer B.A., Palotie A., Ruppert A.-K., Suls A., Siren A., Koeleman B., Haberlandt E., Ronen G.M., Caglayan H., Hjalgrim H., Muhle H., Schulz H., Helbig I., Altmüller J., Geldner J., Schubert J., Jabbari K., Everett K., Feucht M., Balestri M., Nothnagel M., Striano P., Møller R.S., Nabbout R., Balling R., Baulac S., Bianchi A., La Neve A., Minetti C., Giuseppe C.
Published 2019